Enzyme-based medical products

Enzymatica

Enzymatica is based in Lund, Sweden, and sells medical devices against infectious diseases. The company's first product is ColdZyme® Munspray, which is marketed for cold virus prophylaxis and anti-cold virus therapeutic.

Financials

ENZYMATICA

SEKm 2018 2019 2020
Sales 49 56 68
Sales growth (%) -17,9 15 21
EBITDA -35 -22 N/A
EBITDA margin (%) -36,9 -72,5 -39,1
EBIT adj -30 -44 -27
EBIT adj margin (%) -50,8 -91 -48,6
Pretax profit -44 -27 -27
EPS rep -0,47 -0,29 -0,29
EPS growth (%) -40,2 39,2 -1,1
EPS adj -0,47 -0,29 -0,29
DPS 0 0 0
EV/EBITDA (x) -6,7 -12 -13,3
EV/EBIT adj (x) -5,4 -9,7 -10,7
P/E (x) -4,6 -7,6 -7,5
P/E adj (x) -4,6 -7,6 -7,5
EV/sales (x) 4,9 4,7 4,3
FCF yield (%) -20,7 -12,1 -13
Dividend yield (%) 0 0 0
Net IB debt/EBITDA -1 -2,7 -4

Main shareholders

Enzymatica

Main shareholders Share capital % Voting shares % Verified
Mats K Andersson 11.1 % 11.1 % 12 Dec 2018
Gudmundur Palmasson 10.3 % 10.3 % 15 Mar 2017
Agusta Gudmundsdottir 9.8 % 9.8 % 31 Dec 2016
Danica Pension 7.9 % 7.9 % 31 Dec 2018
Håkan Roos 4.4 % 4.4 % 31 Dec 2018
Fibonacci Asset Management AB 4.3 % 4.3 % 31 Dec 2018
Avanza Pension 1.5 % 1.5 % 31 Dec 2018
Ulf Blom 1.4 % 1.4 % 31 Dec 2018
Jörgen Rexö 1.4 % 1.4 % 31 Dec 2018
Nordnet Pensionsförsäkring 1.2 % 1.2 % 31 Dec 2018
Source: Holdings by Modular Finance AB

Insider list

Enzymatica

Name
Louise Nicolin
Abanico Invest AB
Abanico Invest AB
Fiddevången Aktiebolag
Mats Kristian Andersson
Abanico Invest AB
Bengt Baron
Therese Filmersson
Bengt Baron
Andersson & Co Invest AB
Show More